跳至主要内容
临床试验/NCT04790357
NCT04790357Unknown不适用

Assessment of One-shot Cardiac-cervical-intracranial MRI in the Etiological Work up of Ischemic Stroke and Transient Ischemic Attacks

Hospices Civils de Lyon2 个研究点 分布在 1 个国家目标入组 244 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
244
试验地点
2
主要终点
To evaluate the consistency between the reference strategy and the cci-MR strategy for etiological work up according to the ASCOD classification, in ischemic stroke and TIA patients

研究概览

简要总结

Stroke is a major public health issue in developed countries. A full etiological work up within a short time is critical to implement the appropriate preventive treatment. The etiological work up is actually based on a clinical examination and on a group of paraclinical examinations. The realization of the standard strategy is time consuming, and increase the cost of the medical care. A non-invasive one-shot examination of the heart, the aorta and the cervical and intracranial arteries (cci-MRI) could overcome these disadvantages.The investigator therefore propose to carry out an overall assessment of the performance of the cci-MR in the etiological work up of ischemic strokes and TIAs compared to the reference strategy

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Man or woman aged from 18 to 85 years old,
  • Patients victims of an ischemic stroke or a TIA in the 2 days before inclusion, Symptoms thought to be consistent with TIA were those defined by the ad hoc Committee established by the Advisory Council for the National Institute of Neurological and Communicative Disorders and Stroke65
  • Rankin score: mRS ≤3
  • Patient having given their free written and informed consent, or preliminary oral informed consent attested by a third party followed by signed informed consent as soon as possible,
  • Affiliated to a social security scheme or equivalent,
  • That are not the subject of any legal protection measures

排除标准

  • •TIA symptoms limited to isolated numbness,
  • changes, or isolated dizziness/vertigo
  • Agitation, severe swallowing
  • Contraindication to an MRI and the injection of gadolinium,
  • Known history of hypersensitivity to the MRI contrast product,
  • Risk of pregnancy or known pregnancy revealed when questioned, Breastfeeding,
  • Patient unable to understand or poorly understanding French.

结局指标

主要结局

To evaluate the consistency between the reference strategy and the cci-MR strategy for etiological work up according to the ASCOD classification, in ischemic stroke and TIA patients

时间窗: Within 8 days after hospitalization

The primary endpoint will be based on the consistency for each patient of the etiological work up according to the ASCOD classification evaluated with cci-MR in comparison of the reference strategy

次要结局

  • To assess the improvement of the detection of myocardial scar with cci-MR compared to reference strategy(Within 8 days after hospitalization)
  • To evaluate the agreement between cci-MR and the reference method for each etiological subgroup: in the context of ischemic stroke or TIA.(Within 8 days after hospitalization)
  • To assess the atherosclerotic burden (coronary, intracranial, cervical, aortic) assessed with cci-MR compared to the reference strategy,(Within 8 days after hospitalization)
  • To assess the rate of additional cardiologic advice recommended according to the opinion of the expert committee from data obtained with cci-MR and with the reference strategy(Within 8 days after hospitalization)
  • To assess the feasibility of the examinations (rate of completed examinations, deadline to obtain each examination, deadline to obtain all examinations including in each strategy)(Within 8 days after hospitalization)
  • To assess the additional yield of cci-MR in cryptogenic patients and in those with embolic stroke of undetermined source (ESUS) with the reference strategy (ref Hart et al., Lancet Neurol. 2014:13:429-438.)(Within 8 days after hospitalization)
  • To assess the rate of TEE recommended according to the opinion of the expert committee from data obtained with cci-MR and the reference strategy(Within 8 days after hospitalization)
  • To assess the feeling of the patient about cci-MR and the reference strategy(Within 8 days after hospitalization)
  • To assess the reproducibility of the assessment of the cci-MR results(Within 8 days after hospitalization)
  • To assess the preventive treatment recommended (antithrombotic drugs and specific treatments) according to the opinion of the expert committee from data obtained with cci-MR and with the reference strategy(Within 8 days after hospitalization)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验